Cleared Traditional

Fibroid Mapping Reviewer Application (FMRA) (K222683) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222683 · Nesa Medtech Private Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2023
Decision
314d
Days
Class 2
Risk

K222683 is an FDA 510(k) clearance for the Fibroid Mapping Reviewer Application (FMRA). Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Nesa Medtech Private Limited (Bengaluru, IN). The FDA issued a Cleared decision on July 17, 2023 after a review of 314 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Nesa Medtech Private Limited devices

Submission Details

510(k) Number K222683 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2022
Decision Date July 17, 2023
Days to Decision 314 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
207d slower than avg
Panel avg: 107d · This submission: 314d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Medical Device Academy, Inc.
Rob Packard

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 787
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K222683.
Efai Pacs Picture Archiving and Communication System Pro
K232100 · Ever Fortune.Ai, Co., Ltd. · Aug 2023
Patient Specific Planning Solution™ 3D Bone Models
K230540 · Biomet Manufacturing Corp · Jul 2023
Argus Cognitive ReVISION Software
K223322 · Argus Cognitive, Inc. · Jul 2023
CommandEP Data Manager PC (DPC02), CommandEP HMD (HMD02)
K223290 · Sentiar, Inc. · Jul 2023
Cercare Medical Neurosuite
K230016 · Cercare Medical A/S · Jul 2023
JiveX (Model Number / Release: 5.4)
K231041 · Visus Health IT GmbH · Jul 2023